BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35070429)

  • 1. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
    Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
    J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B
    BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
    Front Oncol; 2022; 12():931140. PubMed ID: 36465354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between circulating tumor cells undergoing EMT and short-term efficacy following interventional treatment in patients with hepatocellular carcinoma.
    Chen M; Xu R; Wu L; Chen X
    J Interv Med; 2020 Sep; 3(3):146-150. PubMed ID: 34805926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.
    Sun B; Ji WD; Wang WC; Chen L; Ma JY; Tang EJ; Lin MB; Zhang XF
    Front Genet; 2023; 14():1265866. PubMed ID: 38028589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of various hepatectomy procedures on circulating tumor cells in postoperative patients: a case-matched comparative study.
    Lei Y; Wang X; Tian Y; Xu R; Pei J; Fu Y; Sun H; Wang Y; Zheng P; Xia F; Wang J
    Front Med (Lausanne); 2023; 10():1209403. PubMed ID: 37841010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.
    Lei Y; Wang X; Sun H; Fu Y; Tian Y; Yang L; Wang J; Xia F
    Front Oncol; 2021; 11():601668. PubMed ID: 34123777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.
    Bai T; Mai R; Ye J; Chen J; Qi L; Tang J; Wei M; Zhang L; Chen Z; Tang Z; Li L; Wu F
    Transl Cancer Res; 2020 Mar; 9(3):1384-1394. PubMed ID: 35117486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
    Cheng Y; Luo L; Zhang J; Zhou M; Tang Y; He G; Lu Y; Wang Z; Pan M
    J Gastrointest Surg; 2019 Dec; 23(12):2354-2361. PubMed ID: 30805878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
    Yin LC; Luo ZC; Gao YX; Li Y; Peng Q; Gao Y
    Biomed Res Int; 2018; 2018():3789613. PubMed ID: 30046595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
    Luo Q; Wang C; Peng B; Pu X; Cai L; Liao H; Chen K; Zhang C; Cheng Y; Pan M
    Front Oncol; 2020; 10():1758. PubMed ID: 33224869
    [No Abstract]   [Full Text] [Related]  

  • 14. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.
    Sun YF; Wang PX; Cheng JW; Gong ZJ; Huang A; Zhou KQ; Hu B; Gao PT; Cao Y; Qiu SJ; Zhou J; Fan J; Guo W; Yang XR
    Cancer Cytopathol; 2020 Oct; 128(10):733-745. PubMed ID: 32501632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma.
    Zhang Q; Xing W; Zhang J; Hu J; Qi L; Xiang B
    Onco Targets Ther; 2021; 14():1543-1552. PubMed ID: 33688202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of preoperative circulating tumor cells for hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score analysis.
    Yu JJ; Li YN; Shu C; Yang HY; Huang Z; Tao R; Chen YY; Chen XP; Xiao W
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8981-8991. PubMed ID: 37160624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases.
    Tien YW; Kuo HC; Ho BI; Chang MC; Chang YT; Cheng MF; Chen HL; Liang TY; Wang CF; Huang CY; Shew JY; Chang YC; Lee EY; Lee WH
    Medicine (Baltimore); 2016 Apr; 95(16):e3407. PubMed ID: 27100430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation.
    Chen Z; Lin X; Chen C; Chen Y; Zhao Q; Wu L; Wang D; Ma Y; Ju W; Chen M; He X
    Ann Transl Med; 2020 Sep; 8(17):1067. PubMed ID: 33145286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma.
    Yu J; Wang Z; Zhang H; Wang Y; Li DQ
    World J Gastroenterol; 2021 Nov; 27(43):7546-7562. PubMed ID: 34887648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype.
    Yu JJ; Shu C; Yang HY; Huang Z; Li YN; Tao R; Chen YY; Chen Q; Chen XP; Xiao W
    Front Oncol; 2021; 11():734564. PubMed ID: 34722281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.